Aggressive Lipid Lowering Controls Atherosclerosis Effects

Courtesy MedPage Today Infectious Disease  Thu, 12/04/2008 - 09:02

WASHINGTON (MedPage Today) -- Diabetic patients who reached aggressive lipid-lowering targets saw nearly identical vascular benefits whether on high-dose statins alone or with ezetimibe (Zetia), researchers found.


 

More related items

Survey Report: Many Doctors Stand by Ezetimibe (Zetia)
A sizeable minority of doctors continues to believe that ezetimibe (Zetia) is a powerful agent for their patients, according to a MedPage Today poll.

ASMBS: Statin Use Lower after Gastric Bypass (CME/CE)
LAS VEGAS (MedPage Today) -- Hyperlipidemic obese patients had more than a 90% reduction in need for lipid-lowering therapy following laparoscopic gastric bypass surgery, long-term data from...

ESC: SEAS Data Answer Some Questions But Raise Other...
MUNICH (MedPage Today) -- Results of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial presented here left the potent lipid-lowering combination Vytorin still floundering in...

Burt's Bees Free Head to Toe Starter Kit

Lobe Wonder Ear Support Patches For Earrings,...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com